Fantastic news!
A huge thank you to #CellAndGeneTherapyCatapult for donating £6,500 💜
Their support helps break down barriers to STEM for disabled & neurodivergent young people.🔬
Check out their incredible work in cell & gene therapy: ct.catapult.org.uk
#ThankYou #FutureScientists
A huge thank you to #CellAndGeneTherapyCatapult for donating £6,500 💜
Their support helps break down barriers to STEM for disabled & neurodivergent young people.🔬
Check out their incredible work in cell & gene therapy: ct.catapult.org.uk
#ThankYou #FutureScientists
![[Image Description]
A group of people, most wearing white lab coats, stand in a modern laboratory space with bright blue lighting. They are gathered in front of large glass windows that look into a high-tech lab filled with scientific equipment and cables overhead. In the foreground, one person in a patterned dress is speaking with a lab-coated individual. On the left and right edges of the image is a blue graphic overlay with circular molecule-style designs. At the top left, the Lightyear Foundation logo is displayed. At the bottom, bold text reads: “Thank you CATAPULT Cell and Gene Therapy.”](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:nd3f2t3xidrjnvguvizqipz6/bafkreifd4gj2ydxojglygz52adq4lxwgfw4qjb2u6ivsukr7bndxoscbjm)
August 20, 2025 at 4:56 PM
Fantastic news!
A huge thank you to #CellAndGeneTherapyCatapult for donating £6,500 💜
Their support helps break down barriers to STEM for disabled & neurodivergent young people.🔬
Check out their incredible work in cell & gene therapy: ct.catapult.org.uk
#ThankYou #FutureScientists
A huge thank you to #CellAndGeneTherapyCatapult for donating £6,500 💜
Their support helps break down barriers to STEM for disabled & neurodivergent young people.🔬
Check out their incredible work in cell & gene therapy: ct.catapult.org.uk
#ThankYou #FutureScientists
@cgtcatapult.bsky.social will invest in Lir Therapeutics, through the @innovateuk.bsky.social Cross Catapult Investment Pilot.
Learn more: https://loom.ly/slsXrhk
#InnovateUK #CatapultNetworks #CellandGeneTherapyCatapult
Learn more: https://loom.ly/slsXrhk
#InnovateUK #CatapultNetworks #CellandGeneTherapyCatapult
June 2, 2026 at 9:01 AM
@cgtcatapult.bsky.social will invest in Lir Therapeutics, through the @innovateuk.bsky.social Cross Catapult Investment Pilot.
Learn more: https://loom.ly/slsXrhk
#InnovateUK #CatapultNetworks #CellandGeneTherapyCatapult
Learn more: https://loom.ly/slsXrhk
#InnovateUK #CatapultNetworks #CellandGeneTherapyCatapult
#CGTCatapult #patientaccess #CellandGeneTherapyCatapult #advancedtherapies #lifesciences #lifescienceseconomy #cellandgenetherapy #cellandgenetherapyindustry #advancedtherapyclinicaltrials #CGTCatapultsupportedcompanies #pharmaindustry #healthcare #advancedtherapiessector
zurl.co/NISUD
zurl.co/NISUD
Advanced therapies boost UK’s life sciences ambitions - PharmaTimes
CGT Catapult annual review shows sector’s impact on economy and patient access
pharmatimes.com
November 17, 2025 at 9:52 AM
#CGTmanufacturing #CellularOrigins #Constellation #cellandgenetherapymanufacturing #cellandgenetherapies #CGT #CGTproduction #CellandGeneTherapyCatapult #CGTCatapult #ResolutionTherapeutics #biomanufacturing #robotictechnologies #bioreactortechnology #Autolomous
pharmaphorum.com/news/uk-proj...
pharmaphorum.com/news/uk-proj...
UK project addresses capacity issue in CGT manufacturing
A UK consortium has been set up to tackle a major issue in the development of cell and gene therapies (CGT) – a lack of manufacturing capacity.
pharmaphorum.com
July 17, 2025 at 9:53 AM
#advancedtherapyclinicaltrials #CellandGeneTherapyCatapult #CGTCatapult #UKtrials #UK #clinicaltrials #phaseItrials #AdvancedTherapyMedicinalProductClinicalTrialsDatabase #ATMPClinicalTrialsDatabase #globaltrials #Europeantrials #Genetherapies #ATMPclinicaltrials
pharmatimes.com/news/uk-sees...
pharmatimes.com/news/uk-sees...
UK sees 70% increase in phase I advanced therapy clinical trials in 2024 - PharmaTimes
Cell and Gene Therapy Catapult reveals significant growth in UK trials
pharmatimes.com
January 21, 2025 at 10:34 AM
